← Back to headlines
Mpm Bioventures Sells $461,545 Stake in Entrada Therapeutics
Investment firm Mpm Bioventures has sold shares worth $461,545 in biotech company Entrada Therapeutics, according to recent filings.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Corporate Dividend Declarations Include Nvidia, Mosaic, and Alamos Gold
18m ago
Major Canadian Banks Report Strong Third-Quarter Earnings, Beating Forecasts
45m ago
Anthropic Introduces Framework for AI Agents to Control Physical Devices
1h ago
China Launches Yearlong Vehicle Quality Drive and Recalls Mandate
1h ago